Page last updated: 2024-11-07

pilocarpine and Charcot-Marie-Tooth Disease

pilocarpine has been researched along with Charcot-Marie-Tooth Disease in 1 studies

Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.

Charcot-Marie-Tooth Disease: A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keltner, JL1
Swisher, CN1
Gay, AJ1
Hepler, RS1

Other Studies

1 other study available for pilocarpine and Charcot-Marie-Tooth Disease

ArticleYear
Myotonic pupils in Charcot-Marie-Tooth disease. Successful relief of symptoms with 0.025% pilocarpine.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1975, Volume: 93, Issue:11

    Topics: Adult; Charcot-Marie-Tooth Disease; Child; Eye Diseases; Female; Humans; Male; Methacholine Compound

1975